# Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients

> **NCT00558961** · PHASE1,PHASE2 · TERMINATED · sponsor: **Jewish General Hospital** · enrollment: 13 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** Gleevec and Chlorambucil

## Key facts

- **NCT ID:** NCT00558961
- **Lead sponsor:** Jewish General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-10
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Unsatisfactory enrollment
- **Last updated:** 2023-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00558961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00558961, "Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00558961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*